Hims & Hers Health Inc (NYSE:HIMS)’s traded shares stood at 3.85 million during the last session, with the company’s beta value hitting 0.90. At the close of trading, the stock’s price was $15.74, to imply a decrease of -0.51% or -$0.08 in intraday trading. The HIMS share’s 52-week high remains $17.16, putting it -9.02% down since that peak but still an impressive 64.1% since price per share fell to its 52-week low of $5.65. The company has a valuation of $3.37B, with an average of 5.08 million shares in intraday trading volume over the past 10 days and average of 4.58 million shares over the past 3 months.
Hims & Hers Health Inc (NYSE:HIMS) trade information
After registering a -0.51% downside in the last session, Hims & Hers Health Inc (HIMS) has traded red over the past five days. The stock hit a weekly high of 17.16, dropping -0.51% in its intraday price action. The 5-day price performance for the stock is -4.49%, and 17.20% over 30 days. With these gigs, the year-to-date price performance is 76.85%. Short interest in Hims & Hers Health Inc (NYSE:HIMS) saw shorts transact 12.76 million shares and set a 1.71 days time to cover.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Looking at statistics comparing Hims & Hers Health Inc share performance against respective industry, we note that the company has outperformed competitors. Hims & Hers Health Inc (HIMS) shares are 155.52% up over the last 6 months, with its year-to-date growth rate higher than industry average at 190.91% against 20.00%. Revenue is forecast to grow 120.00% this quarter before jumping 133.30% for the next one. The rating firms project that company’s revenue will grow 35.70% compared to the previous financial year.
Revenue forecast for the current quarter as set by 9 analysts is $270.5 million. Meanwhile, for the quarter ending Jun 2024, a total of 9 analyst(s) estimate revenue growth to $288.5 million.Earnings reports from the last fiscal year show that sales brought in $190.77 million and $204.96 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 41.80% before jumping 40.80% in the following quarter.
HIMS Dividends
Hims & Hers Health Inc has its next earnings report out between May 06 and May 10. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Hims & Hers Health Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Hims & Hers Health Inc insiders hold 11.76% of total outstanding shares, with institutional holders owning 61.81% of the shares at 70.05% float percentage. In total, 61.81% institutions holds shares in the company, led by Vanguard Group Inc. As of Jun 29, 2023, the company held over 13.7 million shares (or 6.76% of shares), all amounting to roughly $128.76 million.
The next major institution holding the largest number of shares is Blackrock Inc. with 9.93 million shares, or about 4.90% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $93.33 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund as the top two Mutual Funds with the largest holdings of the Hims & Hers Health Inc (HIMS) shares. Going by data provided on Jun 29, 2023, Vanguard Total Stock Market Index Fund holds roughly 4.52 million shares. This is just over 2.23% of the total shares, with a market valuation of $42.49 million. Data from the same date shows that the other fund manager holds a little less at 3.63 million, or 1.79% of the shares, all valued at about 34.13 million.
